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The integrity of our genetic material is under constant attack from numerous endogenous and exogenous
agents. The consequences of a defective DNA damage response are well studied in proliferating cells, espe-
cially with regards to the development of cancer, yet its precise roles in the nervous system are relatively
poorly understood. Here we attempt to provide a comprehensive overview of the consequences of genomic
instability in the nervous system. We highlight the neuropathology of congenital syndromes that result from
mutations in DNA repair factors and underscore the importance of the DNA damage response in neural devel-
opment. In addition, we describe the findings of recent studies, which reveal that a robust DNA damage
response is also intimately connected to aging and the manifestation of age-related neurodegenerative dis-
orders such as Alzheimer’s disease and amyotrophic lateral sclerosis.Introduction
Upon analyzing the data collected in the 2000 census, health
officials arrived at the remarkable prediction that by the year
2050, approximately 800,000 Americans would live to see their
hundredth birthday (Park, 2010). Even with the benefits of mod-
ern medical technology, it is miraculous that our bodies can
sustain themselves for a century. Each cell in the human
body incurs thousands of lesions per day to its constituent
lipids, proteins, and nucleic acids from sources that range
from the products of cellular metabolism to the myriad envi-
ronmental chemicals, pollutants, and high-frequency electro-
magnetic radiation. While some cells only need to endure this
onslaught for a short time and are replaced continuously (for
instance, epithelial cells lining the intestine have an average
lifespan of 5 days), others such as neurons are retained for
life and therefore require the means to cope with a lifetime of
damage.
All biological macromolecules are susceptible to corruption;
however, damage to a cell’s genomic DNA is particularly harmful
because DNA is the blueprint for protein production and, unlike
other molecules, it cannot simply be replaced by resynthesis.
DNA damage induces mutations and chromosomal aberrations
that can lead either to cellular dysfunction or to the formation
of cancer, and encounters with certain DNA lesions can derail
transcription and replication, and thereby trigger cell death,
senescence, and aging (Hoeijmakers, 2009). Accordingly, cells
devote enormous resources for the purpose of genome mainte-
nance and have evolved elaborate systems to repair damaged
DNA. In this Review, we focus on the consequences of DNA
damage in the nervous system, taking into account the insights
obtained from neurological disorders that manifest from a defec-
tive DNA damage response. A majority of these disorders are
congenital; however, several recent studies suggest that defec-
tive DNA repair also underlies brain aging and age-associated
neurodegeneration andwe also discuss the implications of these
studies.266 Neuron 83, July 16, 2014 ª2014 Elsevier Inc.The Cellular DNA Damage Response
On any given day, a listing of endogenous DNA damage experi-
enced by a typical mammalian cell would read something as fol-
lows: 200 cytosine deaminations, 3,000 guanine methylations,
10,000 spontaneous depurinations, 10,000–100,000 oxidative
lesions, 10,000 single-strand breaks, and 10–50 double-strand
breaks (Ames et al., 1993; Haber, 1999; Lindahl, 1993; Nakamura
et al., 1998; Vilenchik and Knudson, 2003). To avert the poten-
tially catastrophic consequences of these lesions, cells activate
a highly evolved DNA damage response (DDR) that not only
detects and repairs damaged DNA, but also coordinates repair
with other cellular processes, such as chromatin remodeling,
transcription, cell-cycle progression (in dividing cells), and
apoptosis (Jackson andBartek, 2009). A truly remarkable feature
of the DDR is that each class of lesion elicits its own distinct dam-
age detection and repair mechanism. For instance, thymidine
dimers generated upon exposure to UV light are repaired using
nucleotide excision repair, whereas a separate base excision
repair pathway is utilized to repair oxidative lesions such as
8-oxo-dG. However, the same lesion can also be repaired using
diverse mechanisms depending upon cell-cycle stage, devel-
opmental status, and tissue type. As an example, whereas a
majority of DNA double-strand breaks are repaired through
nonhomologous end joining (NHEJ), a specialized pathway
called homologous recombination (HR) is employed to repair
double-strand breaks that are produced in the S and G2 phases
of the cell cycle.
Although relatively stable compared to other macromolecules,
DNA bases frequently undergomodification by alkylation, oxida-
tion, and deamination. In fact, reactive oxygen species (ROS)
alone generate more than 100 different oxidative base modif-
ications and these alterations have the potential to be highly
mutagenic (Iyama and Wilson, 2013). The brain is thought to
metabolize as much as a fifth of consumed oxygen. Accordingly,
a number of studies have shown that ROS are a major source
of DNA damage in the brain. The base excision repair (BER)
Figure 1. The SSBR Pathway
It is not clear whether BER- and TOP1-mediated
SSBs actually require a sensing step; however,
direct breaks are detected by polyADP ribose
polymerase 1 (PARP1). Various activities collabo-
rate to generate 30 OH and 50 P ends that are
compatible for ligation. For instance, 30 phos-
phoglycolate, and 30 phosphate and 50 OH in-
termediates generated from ROS-mediated sugar
disintegration, and products of abortive TOP1 re-
actions are variously processed by APE1 PNKP
and TDP1, respectively. Occasionally, failure of
ligation can result in the formation of a 50AMP-
associated SSB, which is processed by APTX.
Like in BER, any gap-filling synthesis is mediated
by polb and nicks are sealed by either XRCC1/
LIG3 or FEN1/LIG1.
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main strategy in BER consists of converting the large array of
modified base substrates into a few intermediates that can then
be processed by the core BER components of APE1, polb, and
XRCC1/LIG3. This step is mediated primarily by enzymes called
DNA glycosylases (humans contain at least 15) that specialize in
detecting distinct modified bases and excising them through
cleavage of the N-glycosidic bond (Lindahl, 1974).
Like BER, the nucleotide excision repair (NER) pathway also
resolves modified bases and follows the general program of
damage detection, excision, gap-filling DNA synthesis, and liga-
tion, the distinguishing feature of NER being that it senses struc-
tural distortions in the double helix rather than specific base
modifications. This confers NER with the versatility to operate
on a range of highly diverse substrates, such as the cyclobutane
pyrimidine dimers (CPDs) and 6,4-photoproducts (6-4PPs)Neurongenerated by UV radiation, DNA adducts
that arise from intercalation of chemicals
such as benzopyrene (a component of
cigarette smoke), psoralen, and cisplatin,
and cyclopurines formed by attacks
of the hydroxyl radical on 20-deoxyade-
nosine and 20-deoxyguanosine. These
‘‘bulky’’ lesions typically obstruct the
progression of transcription and replica-
tion machineries and can thereby induce
cellular dysfunction and apoptosis (de
Laat et al., 1999). More than 30 different
proteins work collaboratively in NER,
which is broadly categorized into two
classes, global genome NER (GG-
NER), which resolves lesions throughout
the genome, and transcription-coupled
NER (TC-NER), which specializes in the
removal of damage on the transcribed
strand of DNA within active genes.
In addition to generating numerous
basemodifications,ROS-mediatedattack
on theDNAbackboneandsugar fragmen-
tation can also lead to the formation of
DNA single-strand breaks (SSBs). Moreindirectly, SSBs may also arise as intermediates of the BER
pathway or as by-products of abortive DNA topoisomerase I
(TOP1) reactions (Caldecott, 2008).
The primary challenge in the repair of SSBs is to generate DNA
ends that are compatible for ligation, which is to say, a 30 hydrox-
yl and a 50 phosphate, and depending on the lesion this stepmay
require diverse end-processing activities (Figure 1). Like in BER,
any gap-filling synthesis is mediated by polb and nicks are
sealed by either XRCC1/LIG3 or FEN1/LIG1 (Figure 1).
Under certain conditions, such as the generation of SSBs in
close proximity to each other or encounters between an existing
SSB and either the transcription or replicationmachineries (lead-
ing to their collapse) can cause SSBs to be converted to DNA
double-strand breaks (DSBs). In addition to these, ionizing radi-
ation and chemotherapeutic drugs are prominent environmental
DSB-inducing agents. When compared to other lesions, DNA83, July 16, 2014 ª2014 Elsevier Inc. 267
Figure 2. The NHEJ Pathway of DNA Double-Strand Break Repair
KU70/KU80 heterodimer binds to the broken DNA ends and recruits the cat-
alytic subunit of the DNA-dependent protein kinase, DNA-PKcs. Activation of
DNA-PKcs allows end-processing proteins, such as the ARTEMIS, to access
the broken DNA ends and DNA polymerase (i.e., pol m and pol l) to fill in the
gap. The XRCC4/LIG4 complex is then recruited to promote religation.
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rious because they can cause large chromosome rearrange-
ments that can either lead to cell death or promote tumorigenesis
(Jackson, 2002). Furthermore, even a few DSBs are sufficient to
trigger apoptosis in proliferating cells (although whether neurons268 Neuron 83, July 16, 2014 ª2014 Elsevier Inc.have a higher tolerance for DNA DSB accumulation has not been
thoroughly investigated) (Rich et al., 2000). DSBs are repaired
using one of two main pathways: NHEJ, which involves direct
ligation of the broken DNA ends and is error prone, or HR, which
is selectively utilized in the S and G2 phases of the cell cycle
and employs homologous sequences in the sister chromatid
as a template to ensure error-free repair (Lombard et al., 2005).
Because neurons are postmitotic cells, NHEJ is the primary
pathway of DSB repair in neurons, although HR is probably
important for DNA repair in neural progenitors and nonneuronal
cells in the brain. In NHEJ, DSBs are recognized by the KU70/
KU80 heterodimer, which binds the DNA ends and then recruits
and activates the catalytic subunit of the DNA-dependent pro-
tein kinase, DNA-PKcs. Activation of DNA-PKcs allows end-pro-
cessing activities such as the ARTEMIS, APLF, and PNKP to
access the broken DNA ends and prepare them for ligation.
The XRCC4/LIG4 complex is then recruited, which acts in con-
cert with proteins such as XLF to promote religation (Figure 2).
However, it is important to note that while the importance of
NHEJ in postmitotic neurons in vitro and in newly differentiated
neurons in vivo has been established in various studies, its pre-
cise roles in neurons in the mature brain has not been character-
ized extensively. Studies that involve conditional ablation of
NHEJ factors in the mature nervous system will provide key in-
sights into these issues. Together, the collaborative efforts of
these diverse DNA repair pathways ensure that cells remain
functional despite the numerous lesions they accumulate daily.
Chromatin Modifications in the DNA Damage Response
Both DNA damage and the concomitant response occur in the
context of chromatin. Traditionally, this has been interpreted to
mean that chromatin organization imposes a barrier that must
be overcome to allow DNA repair activities to access damaged
sites, after which the original chromatin configuration is restored.
However, in contrast to this somewhat passive view of chromatin
organization, more recent models emphasize that chromatin
changes in the DDR play active roles in stabilization of the repair
machinery, in the propagation of the DDR, and in the regulation
of transcription in the vicinity of damaged sites (Smerdon, 1991;
Soria et al., 2012). Furthermore, the discovery of roles for histone
deacetylases and other chromatin-compacting activities at the
earliest stages after the induction of DNA damage suggest that
chromatin changes at damaged sites are more dynamic than
previously conceived.
Generally, four main activities are thought to be important for
chromatin changes in response to DNA damage: posttransla-
tional modifications of histone tails and chromatin modifying
enzymes, ATP-dependent chromatin remodelers, histone vari-
ants, and histone chaperones. Although categorized in this
manner, it is important to note that there is extensive crosstalk
between these mechanisms during damage detection, repair,
and the restoration of chromatin organization following repair.
ATP-dependent chromatin remodelers in DNA repair are sum-
marized in Table 1 and the reader is referred to several excellent
reviews on the topics of histone variants and chaperones in the
DDR (Avvakumov et al., 2011; Soria et al., 2012). Here we limit
our discussion to a broad overview of posttranslational chro-
matin modifications in the DDR (Figure 3).
Table 1. Mammalian ATP-Dependent Chromatin Remodelers in DNA Repair
Family Complex Catalytic Subunit Unique Subunit Functions in DNA Repair Reference
Snf2-like
ALC1 CHD1L/ALC1 CHD1L/ALC1 – Implicated in NHEJ and NER (Ahel et al., 2009;
Pines et al., 2012)
Iswi ACF/CHRAC SNF2H ACF1 Facilitates DSBR and NER; ACF1 is
required to recruit KU70
(Lan et al., 2010;
Ura et al., 2001)
Iswi WICH SNF2H WSTF, tyrosine
protein kinase
activity
WSTF phosphorylates H2A.X (Y142)
that is required for gH2A.X expansion
(Xiao et al., 2009)




structure; CHD4 promotes recruitment
of RNF168 and BRCA1
(Goodarzi et al., 2011;
Larsen et al., 2010)
Snf2 BAF/ PBAF BRG1/SMARCA4
or BRM/SMARCA2
BAF170 Facilitates NER; BRM is required to
recruit KU70; BRG1 binds to and
regulates p53 and BRCA1, is part of the
activation loop with gH2A.X and histone
acetylation
(Lee et al., 2010;
Naidu et al., 2009;
Ogiwara et al., 2011;
Peng et al., 2009)
Swr1-like
Ino80 INO80 INO80 ARP5, ARP8 Mediates DSB end resection;
promotes NER
(Gospodinov et al., 2011;
Jiang et al., 2010)
Swr1 NuA4 p400 TIP60 Incorporates H2A.Z-H2B dimers (Ikura et al., 2000;
Xu et al., 2012)
Etl1 SMARCAD1 SMARCAD1 – Regulates end resection in HR (Costelloe et al., 2012)
Rad54-like
ATRX ATRX ATRX – Important for genomic integrity (Leung et al., 2013;
Lovejoy et al., 2012)
Rad54 RAD54 RAD54 – Implicated in many stages of HR (Ceballos and Heyer, 2011)
ERCC6
ERCC6 ERCC6/CSB – – Mutated in Cockayne’s syndrome group B,
participates in transcription-coupled repair
(Orren et al., 1996;
Troelstra et al., 1992)
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through which DNA accessibility, chromatin dynamics, and the
binding of nonhistone proteins are regulated in the DDR. The
N-terminal extensions of histones are the sites of most modifica-
tions, such as poly-ADP-ribosylation, phosphorylation, acetyla-
tion, methylation, ubiquitination, and sumoylation. One of the
earliest detectable modifications following the induction of
DNA strand breaks is poly-ADP-ribosylation (PARylation) that
is mediated by poly- (ADP-ribose) polymerases (PARPs).
PARP1 is a ubiquitous nuclear protein containing an N-terminal
DNA binding domain composed primarily of two zinc finger mo-
tifs, a central BRCT motif containing automodification domain
that mediates interaction with other DNA repair proteins, and
a C-terminal catalytic domain that binds NAD+ and transfers
ADP-ribose from NAD+ to acceptor sites on proteins (Krishnaku-
mar and Kraus, 2010). PARP1 senses DNA strand breaks and
upon activation, catalyzes the assembly of poly- (ADP-ribose)
(PAR) chains onto histones and other protein substrates
including itself. Several lysine residues on histones, such as
K13 of H2A, K30 of H2B, K27 and K37 of H3, and K16 of H4
have been identified as ADP-ribose acceptor sites on histones
(Messner et al., 2010), although glutamate and aspartate resi-
dues have also been identified as acceptor sites on other targets.
The PAR chains cause the nucleation of various chromatin mod-ifiers. For instance, the recruitment of PAR-interacting factors
such as ALC1 and the ATP-dependent chromatin remodeler
SNF2H has also been shown to promote nucleosome sliding
and greater accessibility to DNA ends, whereas the recruitment
of NuRD, polycomb, and macroH2A (an H2A variant) is thought
to mediate chromatin looping and compaction (Ahel et al.,
2009; Chou et al., 2010; Lukas et al., 2011). While chromatin
modulation through PARylation mediates several important
functions in the DDR, it is becoming increasingly clear that the
regulation of PAR levels is also a critical determinant of survival.
PAR levels are tightly regulated through the activities of PAR
glycohyrolase (PARG), which cleaves PAR chains, and terminal
ADP-ribose glycohydrolase (TARG), which removes the proximal
ADP-ribose directly linked to the target protein. Defects in PARG
and TARG1 have been shown to cause neurodegeneration (Tallis
et al., 2014). In addition, prolonged PARP activity can cause
the depletion of NAD+ and trigger an energy crisis within cells,
leading to a form of apoptosis referred to as parthenos.
An extremely well-studied histone modification in the DDR
is the phosphorylation of the histone H2A variant, H2AX, at
Ser139 (gH2AX) (Burma et al., 2001). Three PI-3 kinases, ATM,
ATR, and DNA-PK, are known to phosphorylate H2AX. gH2AX
appears immediately after formation of DNA DSBs and can
spread up to a megabase in the vicinity of the DSB. TheNeuron 83, July 16, 2014 ª2014 Elsevier Inc. 269
Figure 3. Chromatin Modifications in the DDR
The formation of DNA DSBs triggers various chromatin modifications, including poly-ADP-ribosylation mediated by PARP1; histone acetylation/deacetylation
mediated by HAT such as p300,MOF, and TIP60 andHDAC, such as HDAC1, SIRT1 and SIRT6; and ATM-dependent H2AX phosphorylation and RNF8/RNF168-
mediated H2A ubiquitination. ATP-dependent chromatin remodelers can slide, exchange, or evict histone dimers or octamers. The consequences of these
modifications are depicted, with details provided in the text. H2AX containing nucleosomes are shown in orange.
Neuron
Reviewphosphorylation of H2AX at Ser139 is accompanied simulta-
neously by dephosphorylation at Tyr142 and these events allow
recognition of gH2AX by a protein called mediator of DNA dam-
age checkpoint protein 1 (MDC1). The recruitment of MDC1 co-
ordinates virtually every aspect of the DSB signaling response
(Lukas et al., 2011). MDC1 allows for propagation of gH2AX
adjacent to DSB sites, interacts with proteins such as ATM,
TOPBP1, and CHK2, activates checkpoint responses in prolifer-
ating cells, and also coordinates other posttranslational modifi-
cations such as histone ubiquitination and acetylation. For
instance, ATM-mediated phosphorylation of MDC1 stimulates
the recruitment of the H2A ubiquitin ligases RNF8 and RNF168
(Lukas et al., 2011). Ubiquitination of H2A by RNF8 and
RNF168 facilitates the binding sites of downstream factors,
such as breast cancer 1 (BRCA1), p53-binding protein 1
(53BP1), and the E3 ubiquitin-protein ligase RAD18, all of which
are essential for DSB repair.
In addition to these modifications, the significance of histone
acetylation in the DDR has become a major focus of recent
studies. Increased histone acetylation following UV damage is
one of the first identified chromatin modifications associated
with DNA damage. In particular, acetylation of histone H3
Lys56 (H3K56) is believed to promote nucleosome assembly in
DNA repair and DNA synthesis (Das et al., 2009). Similarly, acet-
ylation of H4K16 is known to unfold compact chromatin fibers
(Shogren-Knaak and Peterson, 2006). Consistently, histone ace-
tyltransferases (HATs) that mediate these modifications, such as
MOF, a specific H4K16 HAT, as well as Tip60 and CBP/P300,
less specific HATs that acetylate both histone and nonhistone
proteins, play pivotal roles in DNA repair (Das et al., 2009; Ikura
et al., 2000; Li et al., 2010).
Meanwhile, based on the notion that DNA repair requires chro-
matin relaxation, histone deacetylation and histone deacety-
lases (HDACs) were long believed to only participate at the later
stages of DNA repair, primarily to restore chromatin structure.270 Neuron 83, July 16, 2014 ª2014 Elsevier Inc.However, recent studies in several systems, including postmi-
totic neurons, have unveiled the roles of HDACs and chromatin
compaction in the early phase of DNA repair (Dobbin et al.,
2013; Miller et al., 2010; O’Hagan et al., 2008). Intriguingly,
although acetylation of H3K56 and H4K16 are important for
DNA repair, deacetylation of these residues has been observed
to occur immediately after the formation of DSBs, whereas the
reacetylation is usually observed hours after DNA damage (Miller
et al., 2010). In addition, H4K16 deacetylation facilitates 53BP1
foci formation and NHEJ repair (Hsiao and Mizzen, 2013). Given
the positive role of acH4K16 in transcriptional activation (Taylor
et al., 2013), it is also possible that the transient removal of this
modification serves to inhibit local transcription. Incidentally,
ATM activity was also shown to cause transcriptional silencing
and prevent RNA polymerase II elongation-dependent chro-
matin decondensation in cis of DNA DSBs (Shanbhag et al.,
2010). Histone deacetylation and chromatin compaction may
also prevent the excessive processing of DNA ends and the
uncontrolled expanding of repair factors into adjacent chro-
matin. SIRT6, HDAC1, and HDAC2 have all been implicated as
H3K56 deacetylases, whereas HDAC1 and HDAC2 have been
reported to deacetylate H4K16 (Miller et al., 2010; Toiber et al.,
2013). SIRT6 increases the binding of SNF2H to nucleosomes
and deacetylates H3K56 simultaneously. Decreased SNF2H-
chromatin association, increased H3K56 acetylation, and accu-
mulated DNA damage are detected in the brains of Sirt6 KO
mice, suggesting a physiological role of SIRT6 in maintaining
genomic integrity in the CNS (Schwer et al., 2010; Toiber et al.,
2013). In addition to its deacetylase activity, SIRT6 also has
mono-ADP ribosyltransferase activity and is shown to promote
BER repair through activating PARP1 (Mao et al., 2011; Mosto-
slavsky et al., 2006). Furthermore, the deacetylation of histones
at DSBs is also associated with transient H3K9 methylation
(Price and D’Andrea, 2013). Together, these results suggest
that a compact chromatin state might prevail immediately after
Figure 4. The Lock, Loosen, Load Model of Chromatin Dynamics
DNA damage triggers chromatin compaction in the vicinity of damaged sites
that allows the broken DNA ends to be stabilized or ‘‘locked’’ and to inhibit
transcription in regions adjacent to damaged DNA. This transient state is
quickly followed by chromatin relaxation (‘‘Loosen’’) that allows a plethora of
DNA repair proteins to be recruited (Loaded) to the sites of damage.
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could be important for the synapsis of DNA ends and to inhibit
transcription in regions flanking damaged DNA. This transient
compaction is then followed by an ‘‘open’’ chromatin state that
allows repair proteins to be loaded to DNA damaged sites
(Figure 4).
DNA Repair during Neural Development
Human neural development commences in the third week of
gestation with the specification of neural progenitors during
gastrulation. From the end of gastrulation until about embryonic
day 42 (E42), neural progenitors undergo symmetric divisions
that enormously expand the size of the progenitor pool. There-
after, neural progenitors switch to an ‘‘asymmetric’’ mode of
division wherein each round yields one progenitor cell and one
‘‘postmitotic’’ neuron. Newborn neurons then migrate from the
proliferative zones to their final destinations in various regions
of the CNS, and upon reaching their targets, undergo further
differentiation and ultimately become integrated into functional
networks.
DNA repair is extremely important in the early developmental
stages because unrepaired lesions and mutations at this stage
can have a huge effect on the formation of a functional nervous
system (McKinnon, 2013). In fact, mouse models that involve
germline deletions of various DNA repair factors clearly illustrate
this point. For instance, as mentioned above, polb is the poly-
merase that primarily mediates repair-associated DNA synthesis
in BER and SSBR. Targeted deletion of polb causes neonatal
lethality with widespread apoptosis of newly formed neurons in
the developing CNS and PNS (Sugo et al., 2000). Similarly, dele-
tion of either Xrcc2 or Lig4, which are essential for DSB repair
through HR and NHEJ, respectively, results in embryoniclethality that is also associated with extensive apoptosis in the
nervous system (Orii et al., 2006). Interestingly, Xrcc2/ em-
bryos display massive apoptosis in the brain by E10.5, a stage
that corresponds to the period of neural progenitor proliferation,
whereas no apoptotic cells are detectable in Lig4/ brains until
E12.5, a time period when neural progenitors are differentiating
into neurons (Orii et al., 2006). These observations also reveal
that cells rely on different repair pathways depending on their
status in the developmental program. The reliance on HR-medi-
ated DSB repair during progenitor proliferation has the added
advantage that its utilization probably preserves genetic infor-
mation. In contrast, HR is unlikely to operate in neurons that
have exited the cell cycle and DSB repair through NHEJ be-
comes crucial under these conditions.
Defects in NER and Neurodegeneration: The Cancer
Connection
In addition to mouse models, the numerous congenital diseases
that manifest from mutations in DNA repair factors also under-
score the importance of maintaining genomic stability in the
nervous system (Table 2). For instance, mutations in NER com-
ponents result in syndromes such as xeroderma pigmentosum
(XP), cockayne syndrome (CS), and trichothiodystrophy (TTD),
all of which have neurological components. While all three disor-
ders are characterized by photosensitivity, patients with XP also
show an elevated predisposition to various cancers, including
skin, lung, and mucousmembrane cancers, brain tumors, leuke-
mia, and gastric carcinomas (Kraemer et al., 1987). In fact, such
observations were the first to establish that the development of
cancer is intimately related to the fidelity of DNA repair (Cleaver,
1968). However, about a quarter of XP patients also display a
spectrum of neurological abnormalities that include micro-
cephaly, mental retardation, deafness, cerebellar ataxia, and
peripheral neuropathy, and these clinical presentations suggest
that DNA repair defects are also linked to neurodegeneration
(Iyama and Wilson, 2013; Mimaki et al., 1986). Interestingly, the
fraction of XP patients that develop neurological phenotypes
correspond to those with mutations in genes such as XPA,
XPB, XPD, XPF, and XPG that would cripple both GG-NER and
TC-NER (Iyama andWilson, 2013). However, patients withmuta-
tions in XPC, and hence with defects in GG-NER alone, show no
neurological impairments (Anttinen et al., 2008). Furthermore,
patients with CS and TTD, who also have mutations in genes
that specifically impair TC-NER, but not GG-NER, also show
neurological symptoms but no cancer predisposition (Iyama
and Wilson, 2013). Thus, it appears that the nervous system is
especially susceptible to perturbations in TC-NER.
Neurological Consequences of Unrepaired DNA Strand
Breaks
In addition to defects in NER, neurological abnormalities have
also been observed in individuals harboring hypomorphic
mutations in certain SSBR and DSBR factors. Whereas these
observations have been used as indicators of the importance
of specific repair pathways in the nervous system, the nonover-
lapping phenotypes of mutations in genes within the same repair
pathway have also raised new questions about whether the lack
of DNA repair is in fact the underlying cause of neuropathology inNeuron 83, July 16, 2014 ª2014 Elsevier Inc. 271
Table 2. Human Neurological Diseases Linked to Mutations in DNA Repair Genes
Human Syndromes and Clinical Features Mutated Gene Mouse Models
NER
Cockayne Syndrome (CS): developmental
failure, premature aging, progressive
neurodegeneration, deafness, myelinopathy,
UV sensitivity
ERCC8/CSA Csa ⁄ mice: impaired TC-NER, photoreceptor loss, UV sensitivity,
lacking gross abnormalities (van der Horst et al., 2002)
ERCC6/ CSB Csb mutants mimicing human CS1AN allele: mild CS-like symptoms
including minor neurologic abnormalities; impaired TC-NER; UV
sensitivity (van der Horst et al., 1997)
XPB, XPD Xpb frameshifted homozygous or Xpd null mutants: early embryonic
lethality (may caused by disruption in basal transcription) (de Boer
et al., 1998b); XpbXPCS mutants mimicking human XP11BE allele:
UV hypersensitivity, no overt developmental or aging phenotypes;
Xpa&XpbXPCS double mutants: CS like symptoms including
accelerated aging, neurological defects, big phenotypic variation
(Andressoo et al., 2009)
XPG Xpg ⁄ mice: postnatal growth failure, short life span (Harada
et al., 1999)
Xeroderma Pigmentosum (XP): predisposed
to UV-induced skin cancer, a quarter of XP
patients develop neurological symptoms
including microcephaly, mental retardation,
deafness, cerebellar ataxia, and peripheral
neuropathy
XPA XPG Xpa⁄ or Xpc⁄ mice: UV sensitivity, normal development, no overt
neurological abnormalities; Xpa⁄; Csb⁄ or Xpc⁄; Csb⁄ double
mutants: CS and XP like symptoms including growth retardation,
ataxia, motor dysfunction, reduced cerebellar neurogenesis, and
neurodegeneration (Laposa et al., 2007; Murai et al., 2001); Xpf⁄
mice: UV hypersensitivity, developmental defects, short life span
(Tian et al., 2004)
Trichothiodystrophy (TTD): brittle hair, growth
defects, photosensitivity.80% of TTD patients
show neurological abnormalities including
microcephaly, mental retardation, deafness,
and ataxia
XPD XpdR722W mutants: TTD-like symptoms including brittle hair,
developmental abnormalities, reduced life span, and UV
sensitivity (de Boer et al., 1998a)
TTDA Ttda⁄ mice are embryonic lethal, completely NER deficient,
hypersensitive to oxidative DNA damage (Theil et al., 2013)
SSBR
Ataxia with Occulomotor Apraxia-1 (AOA1):
ataxia, occulomotor apraxia, cerebellar atrophy,
and cognitive impairments
APTX Aptx⁄; Tdp1⁄ mice: significantly slower SSBR rate with intact
DSBR (El-Khamisy et al., 2009)
Spinocerebellar Ataxia with Axonal Neuropathy
(SCAN1): cerebellar atrophy
TDP1 Tdp1⁄ mice: progressive cerebellar atrophy, defects in SSB repair
(Katyal et al., 2007)
DSBR
Ataxia Telangiectasia (A-T): ataxia, widespread
cerebellar atrophy, occulomotor apraxia,
dysarthria, immunodeficiency, and cancer
predisposition
ATM Atm⁄ mice: growth retardation, immunodeficiency, meiotic failure,
cancer predisposition, and no obvious cerebellar atrophy. One
mutant line shows abnormal motor function (Barlow et al., 1996),
the other reveals microglia activation and mild cerebellar degeneration
(Kuljis et al., 1997; Xu et al., 1996)
A-T Like Disease (ATLD): ataxia, dysarthria,
and occulomotor apraxia
MRE11 Mre11⁄ or Mre11H129N/H129N (disrupting nuclease activity) mice: early
embryonic lethality, genome instability, although Mre11H129N/H129N can
activate ATM normally (Buis et al., 2008)
ATR-Seckel Syndrome: microcephaly, dwarfism ATR Atr⁄ mice: early embryonic lethality (de Klein et al., 2000); Atr S/S
(mimicking seckel mutation, a severe hypomorphism): microcephaly,
dwarfism, accumulated replicative stress, progressive aging (Murga
et al., 2009)
Nijmegen Breakage Syndrome (NBS):
microcephaly, immunodeficiency and
cancer predisposition
NBS1 Nbs1⁄ mice: early embryonic lethality (Zhu et al., 2001)
LIG4 Syndrome: microcephaly LIG4 Lig4⁄ mice: late embryonic lethality; p53 dependent apoptosis of
postmitotic neuron (Frank et al., 1998, 2000)




XLF⁄ mice: no obvious neuronal cell death, relatively normal
lymphocyte development, increased ionizing radiation sensitivity
(Li et al., 2008).




Reviewthese diseases. Despite this concern, however, it is impossible
to ignore that mutations in diverse genes, whose products
have well-characterized roles in the cellular DDR, have severe
neuropathological effects.
Perhaps the most detailed insights into the role of DNA dam-
age in the nervous system have come from studies of ataxia
telangiectasia (A-T) and related disorders. A-T is caused by
mutations in ATM, a large serine/threonine kinase that is rapidly
recruited to DNA DSBs and coordinates virtually all aspects of
the cellular DSB response, including DNA repair, checkpoint
activation, and apoptosis (Shiloh and Ziv, 2013). Although A-T
is a multisystem disease in which patients display radiosensi-
tivity, immunodeficiency, and a predisposition to malignancy,
its hallmark features are neurological. These include defects in
movement and coordination (ataxia) that develop early in child-
hood and confine patients to awheelchair by their teenage years,
marked cerebellar atrophy, lack of natural eye movements
(occulomotor apraxia), and slurred speech (dysarthria) (Biton
et al., 2008). Like with XP, the coincidence of neurodegeneration
and cancer predisposition in individuals with mutations in a DDR
factor suggests that the neurological defects in A-T might also
arise from defects in the DDR.
A disorder related to A-T known simply as A-T-like disease
(ATLD) is caused by mutations in MRE11 (Stewart et al., 1999).
ATLD is an extremely rare disease, with only nine families and
a total of 20 affected patients identified worldwide (Palmeri
et al., 2013). Like individuals with A-T, ATLD patients also
display ataxia, dysarthria, and occulomotor apraxia, although
these features appear later in ATLD compared to A-T (Taylor
et al., 2004). In the DSB response, the MRN complex
(comprising MRE11, RAD50, and NBS1) initially recognizes
and binds the broken DNA ends and then rapidly recruits and
activates ATM. The similarities between A-T and ATLD only
reinforce the notion that a defective DDR underlies the neuro-
pathology in these diseases. However, the situation becomes
complicated when one takes into account that mutations in
another member of the MRN complex, NBS1, causes a disease
called Nijmegen breakage syndrome (NBS), in which the primary
neuropathological feature is microcephaly and not the progres-
sive cerebellar degeneration that characterizes A-T and ATLD
(Digweed and Sperling, 2004). Furthermore, in contrast to the
situation in the nervous system, NBS shares many of the other
features of A-T, including radiosensitivity, immunodeficiency,
and cancer predisposition.
Although the reason for the differences between NBS, ATLD,
and A-T are not fully understood, an analysis of neural tissue
from mouse models carrying human ATLD and NBS mutations
is at least partially illuminating (Shull et al., 2009). When these
mice were subjected to genotoxic stress induced by ionizing ra-
diation, widespread apoptosis was observed in nervous systems
of Nbs1 mutant mice, but not in the Mre11 mutants. Similar to
Mre11 mutants, Atm/ mice were also resistant to DNA dam-
age-induced apoptosis after ionizing radiation (Shull et al.,
2009). From these studies, it appears that while both MRE11
and NBS1 are important for ATM activity, mutations in these
components have different effects on ATM-mediated apoptosis
following DNA damage induction. Thus, while human NBSmuta-
tions elevate the level of DNA damage, NBS neurons also seemto possess sufficient ATM activity to trigger neural apoptosis,
which results in microcephaly. On the other hand, human
ATLD and A-T mutations essentially preclude apoptotic ATM
activity and thereby allow damaged neurons to survive. These
dysfunctional neurons probably perish in the long run, which
results in neurodegeneration. Such an explanation is also sup-
ported by an examination of mice lacking Ligase IV, which is a
core component of the NHEJ machinery and is essential for
the repair of DNA DSBs. In humans, hypomorphic mutations in
LIG4 result in LIG4 syndrome that is characterized by micro-
cephaly and this feature is recapitulated in mice harboring a con-
ditional deletion of Lig4 in the nervous system (O’Driscoll et al.,
2001; Shull et al., 2009). Interestingly, themicrocephaly in Ligase
IV-deficient mice can be rescued either by introducing hypomor-
phicMre11mutations or by deleting Atm, but not through muta-
tions in Nbs1 (Shull et al., 2009). Taken together, the overlapping
features of A-T and related disorders and the functional relation-
ship between ATM and MRN in the DDR strongly support the
model that a defective DDR contributes significantly to neurode-
generation.
Notwithstanding the evidence presented above, it still remains
to be shown precisely how defects in the DDR and DNA repair
cause neurodegeneration. In the case of A-T and related disor-
ders, the ideal scenario would consist of a mouse model(s)
that faithfully recapitulates the phenotypes of the correspond-
ing disease in humans and in which at least an accrual of
DNA damage precedes neurodegeneration. However, whereas
ATM-knockout mice exhibit many of the characteristics of A-T,
they show almost none of the neurological phenotypes (Katyal
and McKinnon, 2008). Similarly, mice carrying hypomorphic
Mre11 and Nbs1 alleles are also devoid of neuropathology
(Katyal and McKinnon, 2008). On the one hand, the relatively
short life expectancy of mice might preclude the appearance
of effects that manifest over two decades in humans. On the
other hand, perhaps different thresholds exist for DNA dam-
age-induced apoptosis between the two species. In any case,
the lack of neuropathology in these mouse models (which reca-
pitulate many of the nonneurological aspects of the respective
human diseases) has been perplexing. If the issue is that mice
have a higher threshold for DNA damage-induced apoptosis,
then perhaps introducing mutations that more severely compro-
mise the DDR could breach this threshold. Interestingly, amouse
model in which Nbs1 is conditionally deleted in the CNS seems
to do exactly that (Frappart et al., 2005). While a null mutation
in Nbs1 is embryonic lethal, its selective ablation in the CNS
permits survival. However, the animals display both the micro-
cephaly that is characteristic of human NBS patients, as well
as the severe cerebellar atrophy and ataxia that is seen in A-T
(Frappart et al., 2005). A reason for this striking phenotype could
be that MRN is essential for the activation of not only ATM,
but also another related kinase called ATR that senses single-
stranded DNA generated by stalled or collapsed replication
forks, and coordinates the activation of cell-cycle checkpoints.
Thus, multiple DDR pathways and the survival of both prolifer-
ating progenitors and postmitotic neurons are probably compro-
mised by the loss of Nbs1 in the CNS. These effects provide an
insight into what might be required to model human neurode-
generative diseases in the mouse.Neuron 83, July 16, 2014 ª2014 Elsevier Inc. 273
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Several lines of evidence suggest that SSBs might be at least as
(if not more) crucial in the nervous system. SSBs arise three
timesmore frequently than DSBs and unrepaired SSBs also elicit
a strong apoptotic response (Rulten and Caldecott, 2013). In
addition, while SSBs pose a problem for both proliferating and
postmitotic cells, proliferating cells have more options to repair
SSBs than postmitotic cells. For instance, DNA replication can
convert SSBs into DSBs and these can be accurately repaired
through HR in the S/G2 phases of the cell cycle, whereas such
mechanisms are probably absent in cells like neurons (Rulten
and Caldecott, 2013). The discovery of two disorders called
ataxia with occulomotor apraxia-1 (AOA1) and spinocerebellar
ataxia with axonal neuropathy (SCAN1) further highlights these
points. The interesting feature is that the pathology in these dis-
orders is almost exclusively restricted to the nervous system.
The disease AOA1 is one of the most common forms of spino-
cerebellar ataxia and shares many phenotypic similarities with
A-T, including age of onset, ataxia, occulomotor apraxia, and
cerebellar atrophy caused by a severe loss of Purkinje cells
(Date et al., 2001; Moreira et al., 2001). In addition, AOA1
patients also show cognitive impairments, hypoalbuminaemia,
and hypercholesterolaemia. However, AOA1 patients do not
display the radiosensitivity or a predisposition to cancer that is
seen in A-T patients. AOA1 is caused by mutations in the gene
aprataxin (APTX), which, as mentioned above, is involved in pro-
cessing DNA ends generated as a result of abortive ligation reac-
tions in the SSBR pathway (Date et al., 2001; Moreira et al.,
2001). APTX encodes for a 342 amino acid polypeptide (although
a splice variant of 356 amino acids is also thought to exist) that
consists of three distinct domains: an N-terminal forkhead-asso-
ciated (FHA) domain, a catalytic histidine triad (HIT) domain, and
aC-terminal zinc finger (ZnF)motif (Rass et al., 2007). Through its
FHA domain, APTX interacts with phosphorylated XRCC1 and
XRCC4, whereas multiple domains of the protein bind PARP1
and p53 (Clements et al., 2004; Gueven et al., 2004). These inter-
actions suggest that APTXmight be important for both the repair
of both SSBs and DSBs, although its specific role in DSBR
remains unknown. The HIT-ZnF domain is responsible for the
DNA deadenylase activity of APTX through which it resolves
50-AMP termini and makes them compatible for religation (Ahel
et al., 2006; Rass et al., 2008). A majority of the mutations in
AOA1map to the HIT domain of APTX (Rass et al., 2007). A num-
ber of studies using AOA1 cell lines have reported increased
sensitivity to various DNA damaging agents and neurons lacking
APTX show a specific defect in short-patch SSBR and accumu-
late adenylated DNA nicks (Gueven et al., 2004; Reynolds et al.,
2009). However, like with other disease genes, Aptx/ mice do
not recapitulate the phenotypes of AOA1 patients, making it diffi-
cult to study the neurodegenerative aspects of this disease in
mice (Rulten and Caldecott, 2013).
Compared to AOA1, SCAN1 is an extremely rare disease and
only nine patients from a single Saudi Arabian family have been
discovered until now (Takashima et al., 2002). Like AOA1, pa-
tients with SCAN1 exhibit cerebellar atrophy and show no cancer
predisposition; however, SCAN1 has a later onset than AOA1
(average age of onset is about 15 years) and SCAN1 patients
show no cognitive impairment or occulomotor apraxia and pre-274 Neuron 83, July 16, 2014 ª2014 Elsevier Inc.sent milder hypercholesterolaemia and hypoalbuminaemia
(Takashima et al., 2002). The underlying mutation in SCAN1
has been mapped to a gene that encodes for tyrosyl-DNA phos-
phodiesterase 1 (TDP1) (Takashima et al., 2002). As its name
suggests, TDP1 possesses the ability to hydrolyze a phospho-
tyrosyl linkage at the 30 ends of DNA SSBs and DSBs (Yang
et al., 1996). This sort of linkage usually arises from abortive
TOP1 activity on theDNA (Pourquier et al., 1997). TOP1 is a topo-
isomerase that catalyzes the relaxation of DNA supercoils that
form ahead of an advancing RNA or DNA polymerase. Normally,
in this reaction, TOP1 generates an enzyme-bridged transient
single-strand break in which the 30 end of the DNA becomes
covalently attached to the active site tyrosine in TOP1. The break
then causes the DNA to unwind and become relaxed, after which
the enzyme religates the two ends. However, certain conditions,
such as a collision between a replication fork or RNA polymerase
with a TOP1-DNA complex or the exposure of cells to certain
topoisomerase poisons (such as camptothecin) can result in
the formation of abortive TOP1-DNA complexes and resolving
these intermediates requires TDP1.
Accordingly, SCAN1 cell lines accumulate more DNA SSBs
in the presence of camptothecin compared to control lines and
are also defective in the repair of camptothecin-generated
SSBs (El-Khamisy et al., 2005). In addition, SCAN1 cell lines
also show defects in the repair of SSBs generated by treatment
with hydrogen peroxide and ionizing radiation (El-Khamisy et al.,
2005; Katyal et al., 2007). It is unclear whether these treatments
also result in the accumulation of TOP1-DNA intermediates,
although there is some evidence to suggest that TDP1 might
also process other 30 and 50 termini that arise at SSBs and
DSBs. Interestingly, and unlike a number of other mousemodels,
Tdp1/mice do show a progressive reduction in cerebellar size,
which is consistent with the cerebellar atrophy in SCAN1 pa-
tients, although the mice do not develop ataxia (Katyal et al.,
2007). Given that SCAN1 has a later onset, it is again likely that
the short life expectancy in mice precludes them from devel-
oping other aspects of the disease. Nevertheless, the results
from studies on AOA1 and SCAN1 suggest that the processing
of SSBs and SSBR intermediates, especially abortive TOP1-
DNA complexes, is extremely relevant in neurodegeneration.
DNA Damage in the Aging Brain
No one is immune to aging, the progressive deterioration of
bodily functions with time. Ralph Waldo Emerson wrote ‘‘.old
age seems the only disease, all others run into this one’’ (Essay
X: Circles). In addition to being inevitable, the phenomenon of
aging is also mysterious. For instance, in a classic paper titled
Pleiotropy, Natural Selection and the Evolution of Senescence,
George C.Williams observed, ‘‘It is remarkable that after a seem-
ingly miraculous feat of morphogenesis a complex metazoan
should be unable to perform the much simpler task of merely
maintaining what is already formed’’ (Kirkwood, 2005; Williams,
1957). Yet, maintenance is no simple task in a cellular environ-
ment that constantly threatens the stability of its constituents,
especially its DNA.
The consequences of genomic instability manifest in at least
three important ways with age (Figure 5). The first is an accumu-
lation of unrepaired DNA damage, which can arise from a
Figure 5. The Consequences of DNA
Damage in Aging and Neurodegeneration
Left: erroneous repair of DNA damage can lead to
the formation of mutations, which are irreversible
and perturb tissue homeostasis in the nervous
system by essentially promoting the formation of
mosaics. Occasionally, mutations could occur in
DNA repair factors (such as FUS, see text) and
this can manifest in profound neurodegeneration
(red arrow). Middle: in contrast, although revers-
ible, the accumulation of unrepaired lesions due to
decreased DNA repair activities can block the
transcription of genes encoding for critical neural
functions and downregulate their activity, leading
to cognitive decline. Right: DNA damage also
affects the epigenetic landscape. DNA damage-
induced epigenetic changes can accrue over time
as ‘‘epimutations’’ and affect gene expression. In
addition, the redistribution of epigenetic modula-
tors, such as SIRT1, can trigger global changes
to the chromatin architecture, leading to large-
scale transcriptional deregulation of their normally
repressed targets, such as major satellite repeti-
tive DNA.
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decline in the efficiency of BER and NHEJ due to a reduction in
the activity of DNA glycosylases and DNA-PK, respectively,
has been reported in the literature. An age-dependent attenua-
tion in DNA repair capacity has also been reported in the rodent
and human brain. In an insightful study, microarray analysis of
postmortem human brain samples as a function of age revealed
that genes encoding for critical neuronal functions, including
synaptic plasticity, learning, andmemory, are downregulated af-
ter age 40 and, concomitantly, the expression of stress response
genes is upregulated (Lu et al., 2004). Importantly, this dramatic
change in gene expression profiles is accompanied by an accu-
mulation of oxidative lesions in the promoter regions of the
downregulated genes (Lu et al., 2004), suggesting that an
accrual of oxidative lesions could underlie the decline in cogni-
tive abilities with age.
Another way in which DNA damage participates in aging is
through the erroneous repair of DNA lesions that results in muta-
tions (Vijg and Suh, 2013). In contrast to unrepaired lesions,
which are reversible, mutations are irreversible and can therefore
be highly problematic. For instance, the use of a transgenic
mouse model that harbors a chromosomally integrated reporter
that can be sequenced to assay for mutations as a function of
age revealed that mutations in the liver almost quadrupled with
age (Dolle´ et al., 1997). Interestingly, no such differences were
found in the brain under these conditions. However, only a fewNeuronchromosomal loci were sampled in
this study and it is therefore formally
possible that mutations accumulate at
certain ‘‘hotspots’’ in the aging human
brain. Mutations could also contribute
to age-related neurodegeneration in a
more indirect way. In an interesting study,
single-cell genomic analysis of postmor-
tem neurons from the human frontal
cortex revealed that between 13% and41% of neurons have copy number variations (CNVs) of at least
one megabase (McConnell et al., 2013). The specific conse-
quences of somatic mosaicism in the human brain are presently
unknown; however, it would be interesting to determine whether
CNVs in the brain increase as a function of age or in certain
age-related neurodegenerative disorders. A more direct effect
of mutations on neurodegeneration is clearly evident when these
mutations compromise the activities of DNA repair/DDR factors
(see below).
In addition to direct alterations to the composition and struc-
ture of DNA, the formation of DNAdamage also elicits substantial
changes to chromatin organization. While a number of these
changes serve necessary functions in DDR signaling, there is
also evidence to suggest that chromatin conformation might
not be restored to its predamaged state following DNA repair
(Oberdoerffer and Sinclair, 2007; Tamburini and Tyler, 2005).
Thus, DNA damage could progressively alter chromatin con-
formation, and thereby, gene expression patterns, with age. In
fact, a number of studies have reported age-associated changes
in the epigenome (Krishnan et al., 2011; Peleg et al., 2010;
Vijg and Suh, 2013), although precisely what fraction of these
changes is a result of DNA damage remains unclear.
The studies described thus far highlight the local conse-
quences of DNA damage, through lesions, mutations, and
epigenomic changes at the sites of damage. However, other
studies, especially those conducted by Sinclair and colleagues,83, July 16, 2014 ª2014 Elsevier Inc. 275
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chromatin architecture (Oberdoerffer et al., 2008; Oberdoerffer
and Sinclair, 2007). They observed that the exposure of cells
to DNA-damaging agents, including hydrogen peroxide, and
the generation of site-specific DNA DSBs leads to a redistribu-
tion of SIRT1 from various loci, including repetitive DNA ele-
ments, to the sites of DNA damage (Oberdoerffer et al., 2008).
The localization of SIRT1 is essential for DNA repair and there-
fore beneficial in the short term; however, chronic genotoxic
stress during and a persistent redistribution of SIRT1 causes
large-scale transcriptional deregulation of genes normally tar-
geted by SIRT1. Interestingly, the gene expression changes
that result from SIRT1 redistribution parallel those in the aging
mouse brain (Oberdoerffer et al., 2008). These results raise the
possibility that pharmacological SIRT1 activation can impact ag-
ing in at least two ways: by stimulating the repair of damaged
DNA and by promoting the transcriptional regulation of repetitive
elements and other loci normally targeted by SIRT1. In addition
to these mechanisms, telomere dysfunction is thought to be a
major underlying factor in aging (Sahin and DePinho, 2012),
although its specific roles in the aging human brain requires
further characterization.
DNA Damage in Age-Associated Neurodegenerative
Disorders
In addition to normal aging, defective DNA repair has also been
linked with age-associated neurodegenerative disorders such
as Alzheimer’s disease (AD), Parkinson’s disease (PD), and
amyotrophic lateral sclerosis (ALS). For instance, elevated levels
of DNA strand breaks, a reduction in the levels of DSB repair
proteins such as DNA-PKcs and MRN complex proteins, and
decreased BER activity have been described in AD patients
compared to age-matched controls (Adamec et al., 1999;
Jacobsen et al., 2004; Mullaart et al., 1990; Shackelford, 2006).
Similarly, elevated levels of oxidative lesions and SSBs have
been reported in the neurons of ALS patients and damage to
mitochondrial DNA has been documented in PD (Bender et al.,
2006; Kraytsberg et al., 2006; Martin, 2001). While these studies
certainly raise the possibility that defects in the DDR underlie
brain aging and the development of age-related neurodegener-
ative disorders, it should be noted that these studies are largely
correlative in nature and that our understanding of the specific
contribution of DNA damage to the etiology of these disorders
is still only rudimentary. To say that DNA damage has a causal
effect in the neuropathology of AD, PD, or ALS requires speci-
fying what lesions, if any, have a higher propensity to accumulate
in the diseased neurons, identifying the molecular mechanisms
that preclude the repair of these lesions, developing animal
models in which lesion accumulation mimics at least some
aspects of the pathophysiology of human neurodegenerative
disorders, and, ideally, that promoting DNA repair can alleviate
these effects. While an understanding of each of these ques-
tions is currently limited, recent studies are fast changing the
status quo.
A major issue concerns understanding which lesions are cen-
tral to the progression of a given neurodegenerative disease.
Generally, oxidative DNA lesions have received much attention
because the brain has a relatively high metabolic rate, gener-276 Neuron 83, July 16, 2014 ª2014 Elsevier Inc.ates more ROS, and is thought to have a decreased ratio of anti-
oxidant to pro-oxidant enzymes, all of which translates into a
state of elevated oxidative stress (Canugovi et al., 2013). As
mentioned above, the BER pathway is primarily involved in
the repair of oxidative lesions and consists of enzymes called
DNA glycosylases that specialize in lesion recognition and initial
processing. It has been reported that expression and activity of
various BER factors changes both with age and in disorders
such as AD. For instance, the expression of both UDG1 and
bOGG1 glycosylases, as well as polb, were found reduced
in AD brains compared to age-matched controls (Canugovi
et al., 2013). However, knockout mouse models of various
DNA glycosylases show none of the drastic phenotypes
of human neurodegenerative disorders. In addition, transgenic
mouse models of AD do not exhibit BER deficits. On the one
hand, the lack of an overt phenotype in mice lacking DNA
glycosylases is reminiscent of mouse models of the various
neurodevelopmental disorders described above. On the other
hand, whereas mutations in DDR factors actually underlie the
neurodevelopmental disorders, mutations in BER factors have
so far not been observed in neurodegenerative disorders.
Thus, the specific contribution to age-related neurodegenera-
tion of at least the subset of oxidative lesions that are repaired
through BER remains unclear. In contrast to mouse models
of BER mutants, conditional mouse models in which Ercc1
was specifically deleted in excitatory neurons of the forebrain
showed reduced synaptic plasticity in the hippocampus, as
well as memory impairments that are characteristic features of
age-related neurodegenerative disorders (Borgesius et al.,
2011). Because Ercc1 is a component of the NER pathway,
these results raise the possibility that NER deficits could under-
lie age-related neurodegeneration. However, Ercc1 also partic-
ipates in the repair of DNA DSBs and crosslinks and, like with
BER factors, NER mutations have so far not been identified in
age-related neurodegenerative disorders.
In addition to oxidative lesions, the notion that DNA strand
breaks might contribute significantly to the pathology of age-
related neurodegenerative diseases has recently gained trac-
tion. First, DNA strand breaks are elevated in disorders such
as AD and ALS (Adamec et al., 1999; Martin, 2001; Mullaart
et al., 1990). In addition, elevated levels of DNA DSBs have
now been reported in several mouse models of neurodegenera-
tion (Dobbin et al., 2013; Kim et al., 2008; Suberbielle et al.,
2013). Among these, studies conducted on the p25/Cdk5mouse
model have been particularly illuminating. Cyclin-dependent
kinase 5 (Cdk5) is a brain-specific serine/threonine kinase that
requires its cyclin-like partner, p35, for catalytic activity (Lew
et al., 1994; Tsai et al., 1994). Studies conducted over a dozen
years have informed that in the AD brain as well as under other
neurotoxic conditions, p35 undergoes proteolytic cleavage to
generate p25 and that the association of p25 with Cdk5 changes
the substrate specificity and subcellular localization of Cdk5 (Su
and Tsai, 2011). These observations prompted the generation of
the inducible p25/CDK5mousemodel (CK-p25mice) (Cruz et al.,
2003). Upon induction, CK-p25 mice express p25 in a forebrain-
specific manner and systematically recapitulate various AD-like
pathologies including the accumulation of amyloid-b pep-
tides, neurofibrillary tau tangles, astrogliosis, reduced synaptic
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2006). Remarkably, an analysis of presymptomatic CK-p25
mice revealed that an accrual of DNA DSBs in the forebrain pre-
cedes the appearance of all other pathological hallmarks and
suggests that DSBs could be the initiating lesion of neurotoxicity
in these mice (Kim et al., 2008).
The unexpected discovery of DSBs in a mouse model of neu-
rodegeneration triggered further investigations into the mecha-
nisms underlying their accumulation in CK-p25 mice. These
studies attributed the elevated DSBs to an inhibition of the class
I histone deacetylase (HDAC1) in CK-p25 mice and found that
overexpression of HDAC1 suppressed both the increased sus-
ceptibility to DSBs and the neuronal loss caused by p25 overex-
pression (Kim et al., 2008). However, a separate study noted that
overexpression of the NAD+-dependent deacetylase SIRT1 can
also prevent neuronal loss in CK-p25 mice (Kim et al., 2007).
Meanwhile, several groups working in dividing cells reported
that SIRT1 is essential for the recruitment of NBS1 and RAD51
to the sites of DNA DSBs and that HDAC1 plays an important
role in DSB repair through the NHEJ pathway (Oberdoerffer
et al., 2008; Yuan et al., 2007). These observations suggested
that the neuroprotective functions of SIRT1 and HDAC1 in CK-
p25 mice might arise from their roles in the neuronal DSB
response. A direct exploration of the functions of SIRT1 and
HDAC1 in the DSB response of postmitotic neurons has pro-
vided further insights into this question (Dobbin et al., 2013).
Neurons lacking either SIRT1 or HDAC1 are more susceptible
to DSB-inducing agents and are deficient in DSB repair. Both
SIRT1 and HDAC1 also localize rapidly to the sites of DNA
DSBs and SIRT1 specifically exhibits a codependent relation-
ship with ATM for its recruitment to DSBs and also stimulates
the autophosphorylation and activity of ATM (Dobbin et al.,
2013). Interestingly, however, SIRT1 also shares an enzyme-
substrate relationship with HDAC1 in which SIRT1 deacetylates
and stimulates the catalytic activity of HDAC1 and helps recruit
HDAC1 to the sites of DNA damage. The effects of SIRT1 on
HDAC1 activity can also be achieved by treatment with pharma-
cological activators of SIRT1 both in vitro and in vivo (Dobbin
et al., 2013). Finally, pharmacological activation of SIRT1 is
able to stimulate HDAC1 deacetylation, reduce DSB formation
and improve neuronal survival in CK-p25 mice. Taken together,
the studies involving CK-p25 mice not only implicate DSBs as
a lesion that could underlie neurodegeneration, but also provide
new clues into activities that could guard against genomic insta-
bility and preserve neuronal viability.
Although extremely cytotoxic, DSB formation is also incredibly
rare even in proliferating cells, where DNA replication is an
important source of these lesions. The notion of DSBs being
important for age-related neurodegeneration therefore requires
identifying the processes that lead to their formation in the first
place. Interestingly, a recent report indicates that physiological
neural activity, including performing new learning tasks, itself
can introduce DSBs within neurons (Suberbielle et al., 2013).
Moreover, using an ADmousemodel, the authors show that am-
yloid b generation exacerbates the accumulation of these DSBs
(Suberbielle et al., 2013). At present, it is still unclear whether
these DSBs serve a physiological purpose or whether they are
merely a consequence of the changes that occur during neuronalactivation, and further studies in this line should illuminate the
precise risk posed by DSB formation induced during neural
activity. Nonetheless, these results provide new evidence to
suggest that DSBs are in fact produced in neurons under phys-
iological conditions and that their repair could govern neuronal
survival in neurodegenerative diseases.
A potential strategy to determine the role of DDR defects
in age-related neurodegeneration consists of understanding
whether mutations that cause the familial forms of these disor-
ders also perturb the DDR. While such connections remain
largely obscure, recent studies involving the RNA/DNA binding
protein FUS could represent a breakthrough in this direction. In
2009, two studies identified more than a dozen mutations in
FUS that are linked with familial ALS (fALS) and found that these
mutations cause FUS to be deposited in the cytoplasm (Kwiat-
kowski et al., 2009; Vance et al., 2009). Based on its similarity to
another RNA binding protein called TDP-43 that was also impli-
cated in familial ALS, a majority of studies on FUS have since
centered on its role in RNA processing (Lagier-Tourenne and
Cleveland, 2009). Interestingly, however, FUS (which stands
for Fused in Sarcoma) was also shown to be important for
genomic stability more than a decade ago. For instance,
Fus/ mice suffer from high levels of genomic instability,
defective B-lymphocyte development, male sterility, and un-
dergo perinatal death, and FUS was shown to participate in
D-loop formation, which is an intermediate step in DNA repair
through HR (Baechtold et al., 1999; Hicks et al., 2000; Kuroda
et al., 2000). Recently, several independent studies have
demonstrated the rapid recruitment of FUS to laser-induced
DNA damage sites, which is crucial for efficient DSB repair
(Mastrocola et al., 2013; Rulten et al., 2014; Wang et al.,
2013). FUS recruitment to DSBs depends on the enzymatic
activity of PARP-1, but not on DNA-PK or ATM, and in FUS
knockdown neurons, the response to treatment with DSB-
inducing agents is dampened. Moreover, stable tethering FUS
to chromosomes in the absence of a DSB is sufficient to elicit
the DDR (Wang et al., 2013). Thus, FUS appears to be an
early component that participates in the initial steps of DDR
signaling. Furthermore, FUS directly interacts with HDAC1,
and the interacting domains map to the G-rich and C-terminal
domains within FUS, where the majority of the fALS mutations
are also concentrated. fALS FUS mutants display an impaired
interaction with HDAC1 and lead to deficient DNA repair
(Wang et al., 2013). Importantly, when motor cortex samples
from ALS patients harboring C-terminal FUS mutations were
analyzed, it was found that the amount of DNA damage is signif-
icantly enriched compared to normal brain tissues (Wang et al.,
2013). Together, these studies suggest that the dysfunction of
FUS in DSB signaling and repair could contribute to the disease
progression of FUS-linked fALS.
In conclusion, it is becoming increasingly clear that the DNA
damage response is important during both neural development
and in the mature nervous system. Mutations in core DNA
repair factors are either incompatible with life, or, even when
tolerated, manifest in severe neurodevelopmental disorders.
On the other hand, determining the specific contribution of
DNA damage to brain aging and neurodegeneration remains a
complex problem. The vulnerability of postmitotic neurons toNeuron 83, July 16, 2014 ª2014 Elsevier Inc. 277
Neuron
Reviewcertain types of DNA damage (such as oxidative lesions or
certain DNA strand break lesions) coupled with a gradual
decline in the activities of corresponding repair mechanisms
could lead to their accumulation with age and contribute to
brain aging and neurodegeneration. In addition, mutations in
certain DDR factors (such as FUS) could exacerbate these ef-
fects and predispose individuals to neurodegeneration. In the
future, identification of the specific lesions that accumulate in
human age-related neurodegenerative diseases and the gener-
ation of new conditional mouse models are likely to provide key
insights into which activities should be targeted in therapeutic
strategies to combat these disorders.ACKNOWLEDGMENTS
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